Skip to content
FIND A HEALTH VALLEY ACTOR
Swiss Health Valley 25 ans 1

25 Years of Swiss Health Valley: A Quarter Century of Life Sciences Innovation

25 Years of Swiss Health Valley: A Quarter Century of Life Sciences Innovation
20.11.2026
Share this article

Swiss Health Valley🇨🇭… You have all heard the name! For more than two decades, it has regularly made headlines and featured on social media. But how did it all begin?



2001: the spark. EPFL, UNIL, UNIGE, CHUV and HUG joined forces with the cantons of Geneva and Vaud to give life sciences in the region a real boost. At the time, the founders focused on the fifty or so biotech companies based in the region.

2003: the official launch. The BioAlps association was founded, and Fribourg, Neuchâtel and Valais joined the adventure.

2008: new momentum. BioAlps became part of the New Regional Policy and gained the support of the State Secretariat for Economic Affairs (SECO). Today, it is backed by six cantons (Geneva, Vaud, Valais, Fribourg, Neuchâtel and Jura) and 17 academic institutions.



Bringing people together, again and again.

Over the years, BioAlps associaiton has created many opportunities for the community to meet:

  • The BioAlps Networking Day, the Swiss Health Valley’s largest event of the year. The next edition is already set for 11 November 2027 in La Chaux-de-Fonds.
  • Company visits, formerly known as “4 à 6” and now called “Inside”.
  • The Deep Dive conferences.
  • The BioInnovation Day – BIND, launched in 2025, which each year presents around 30 promising early-stage life sciences projects to investors and the public. See you on 22 April 2027 at Campus Biotech in Geneva.




Celebrating excellence

Every year, the BioAlps – Swiss Health Valley Awards honour the region’s talent. The first Industry Award went to Robert Kuster in 2008, and the first Academia Award to Prof. Philippe Renaud of EPFL in 2010. Many have received the distinction since, among them:

  • Debiopharm, AC Immune, Lonza and SOPHiA GENETICS
  • Prof. Didier Pittet
  • Prof. Jocelyne Bloch and Prof. Grégoire Courtine
  • Prof. George Coukos
  • Prof. Olivier Michielin and Prof. Pierre-Yves Dietrich of the Swiss Cancer Center Léman
  • Prof. Pierre Magistretti, in 2025
  • Takeda, in 2024
  • Merck Group, in 2025
  • Edwards Lifesciences and the HUG Vaccinology Centre, at this year’s BioAlps Networking Day
  • And many, many more!



A thriving ecosystem

In 25 years, the Swiss Health Valley has grown remarkably. It now counts 2,400 players across six cantons, including 1,900 companies in medtech, biotech, pharma, digital health, foodtech and cosmetics. A study by BAK Economics for GRIP (Groupement Romand de l’Industrie Pharmaceutique), published in autumn 2026, shows that life sciences generate CHF 28.3 billion in total added value and support more than 83,000 jobs across French-speaking Switzerland.

An incredibly rich ecosystem, and the BioAlps team and executive committee is proud to serve it.

Happy 25th birthday, Swiss Health Valley! 🎂



📸 © Marc Bader. The BioAlps Swiss Health Valley Executive Committee and General Secretary, from L to R

  • Dr. Sacha Sidjanski: External Relations Manager, EPFL
  • Anne-Renée Leyvraz, formerly Expert at Knowledge Transfer UNIL CHUV
  • Dr. Ana Pinto: Business Partner, Canton of Neuchâtel
  • Dr. Alberto Schena: Director, Knowledge Transfer UNIL CHUV
  • Prof. Dr. Christophe Allemann: Head of ChemTech, University of Applied Sciences Western Switzerland
  • Muana Minkoué: Communication & Event Manager, BioAlps-Swiss Health Valley
  • Prof. Dr. Yogeshvar Kalia: Full Professor, School of Pharmaceutical Sciences, UNIGE
  • Sandra Ansanay-Alex: Senior Communication & Event Manager, BioAlps-Swiss Health Valley
  • Magali Bischof: Secretary General, BioAlps Association
  • Denis Cavin: Economic Affairs Officer, Canton of Geneva
  • Dr. Pierre-Jean Wipff: Vice-President. Director of Innovation and Partnerships at Biopôle SA, Canton of Vaud

Not in the picture : 

  • Prof. Antoine Geissbuhler: President. Dean of the Faculty of Medicine, UNIGE
  • Dr Massimo Nobile, CEO of Swiss Biotech Center